|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-9.45/-16.62
|
Enterprise Value
3.90M
|
Balance Sheet |
Book Value Per Share
12.44
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
91.72M
|
Operating Revenue Per Share
58.21
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
![](../images/dot.bmp)
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based onproprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others. |